Last reviewed · How we verify
NCT06181344
Implementation and Evaluation of a Fear of Cancer Recurrence Screening, Referral and Management Program
NA trial testing FCR screening and referral program in Fear of Cancer Recurrence in 1,980 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 1,980 |
| Start date | 26 July 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 August 2026 |
| Sites | 2 locations across Hong Kong |
Drugs / interventions tested
- FCR screening and referral program
Conditions studied
- Fear of Cancer Recurrence — all drugs for Fear of Cancer Recurrence →
- Cancer — all drugs for Cancer →
Sponsor
The University of Hong Kong
Who can join
18 and older, any sex, with Fear of Cancer Recurrence or Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the process and outcomes of an implementation program designed to implement fear of cancer screening, referral and management into routine cancer care clinics, using a stepped-wedge cluster randomized controlled trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06181344
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fear of Cancer Recurrence
Currently open trials in the same condition.
- NCT06872840 — Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility · NA · recruiting
- NCT06554899 — CIFeR - A Clinician-led Intervention to Address Fear of Cancer Recurrence · NA · recruiting
- NCT06207006 — E-intervention on Subclinical Fear of Cancer Recurrence · NA · recruiting
- NCT06767332 — EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial · NA · recruiting
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06181344 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 13 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06181344.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing